Idexx Laboratories (IDXX) Share-based Compensation (2009 - 2026)

Idexx Laboratories has reported Share-based Compensation for 18 years, with the latest figure at $16.1 million in Q2 2026.

• On a quarterly basis, Share-based Compensation rose 8.31% year-over-year to $16.1 million in Q2 2026; TTM through Jun 2026 was $63.0 million, a 5.58% increase from a year earlier, with the FY2025 full-year figure at $60.0 million, changed 0.47% from the prior year.
• Share-based Compensation was $16.1 million for Q2 2026 at Idexx Laboratories, down from $16.3 million in the prior quarter.
• The five-year high for Share-based Compensation was $16.3 million in Q1 2026, with the low at $11.2 million in Q1 2022.
• Average Share-based Compensation over 5 years is $14.6 million, with a median of $14.7 million recorded in 2025.
• The largest YoY upside for Share-based Compensation was 250.52% in 2022 against a maximum downside of 25.43% in 2022.
• Over 5 years, Share-based Compensation stood at $13.3 million in 2022, then climbed by 14.64% to $15.2 million in 2023, then dropped by 6.34% to $14.3 million in 2024, then gained by 13.0% to $16.1 million in 2025, then retreated by 0.14% to $16.1 million in 2026.
• The last three Share-based Compensation figures came in at $16.1 million (Q2 2026), $16.3 million (Q1 2026), and $16.1 million (Q4 2025), per Business Quant data.